+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Human Brain Models Market - Global Forecast 2026-2032- Product Image
Human Brain Models Market - Global Forecast 2026-2032- Product Image
Sale

Human Brain Models Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6126331
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Human Brain Models Market is projected to reach USD 243.33 Million in 2026. It is expected to continue growing at a CAGR of 15.00%, reaching USD 567.82 Million by 2032.

Human Brain Models: Executive Summary and Strategic Context

Human brain models encompass experimental systems used to investigate neural development, brain function, disease mechanisms, and therapeutic responses. The field includes organoids, assembloids, engineered tissue, induced pluripotent stem cell-derived models, computational representations, and complementary animal or ex vivo approaches. Progress is being shaped by the need for more human-relevant biology, improved reproducibility, and research workflows that connect cellular behavior with clinically meaningful outcomes.

Human-Relevant Biology Is Reshaping Brain Research

The landscape is shifting from isolated two-dimensional cultures toward increasingly complex, multicellular, and spatially organized models. Researchers are combining neural and non-neural cell types, vascular or barrier components, immune elements, and region-specific tissues to study interactions that conventional systems often miss. Standardization, quality control, maturation, scalability, and validation against human data remain central challenges as laboratories seek models that are both biologically informative and operationally practical.

Artificial Intelligence Accelerates Design, Analysis, and Validation

Artificial intelligence is strengthening the human brain models workflow by supporting image analysis, cell-state classification, phenotype detection, experimental quality control, and integration of multimodal datasets. Machine-learning tools can help identify subtle morphological or molecular patterns that are difficult to assess manually, while generative and predictive methods may improve experimental design and model selection. Their value depends on well-annotated datasets, transparent validation, avoidance of batch bias, and continued expert review; AI should augment biological judgment rather than replace it.

Regional Ecosystems Differ in Infrastructure, Regulation, and Translation

North America combines strong biomedical research capacity, advanced technology infrastructure, and active translational networks, while Europe emphasizes collaborative science, ethical oversight, and harmonized research practices. Asia-Pacific is supported by substantial investment in biotechnology and growing capabilities in stem-cell engineering, imaging, and automation. Latin America is expanding research activity through academic and clinical partnerships, with infrastructure and funding access varying across countries. The Middle East is developing life-science capacity through institutional investment and international collaboration, while Africa presents important opportunities for locally relevant neuroscience research alongside persistent constraints in equipment, specialized skills, and sustained funding.

International Groups Shape Collaboration and Research Governance

ASEAN provides a platform for cross-border cooperation in a region with varied research capabilities and regulatory environments. BRICS members contribute diverse scientific ecosystems and policy priorities, although coordination and infrastructure differ substantially. The European Union supports multinational programs, shared standards, and data-governance frameworks. G7 countries remain influential in advanced neuroscience, translational research, and responsible innovation discussions. GCC states are strengthening biotechnology and research infrastructure through coordinated investment, while NATO-related collaboration can facilitate scientific exchange, dual-use awareness, and resilience considerations without replacing civilian research governance.

Country Capabilities Reflect Distinct Scientific and Policy Priorities

The United States and Canada have broad research ecosystems spanning stem-cell biology, neuroscience, imaging, and translational development. The United Kingdom, Germany, France, Italy, and Spain contribute established biomedical institutions and regulatory expertise, with European collaboration supporting interoperability. Japan and South Korea are advancing regenerative medicine, automation, and precision measurement, while China is building substantial capabilities across stem-cell research, engineering, and data-intensive biology. India is expanding its biotechnology and neuroscience base. Australia contributes strong biomedical research and clinical links. Brazil and Mexico are important Latin American centers with growing academic capacity. Russia retains relevant scientific expertise, though collaboration conditions and access to international infrastructure can affect research continuity.

Leaders Should Prioritize Validation, Interoperability, and Responsible Scale

Industry and research leaders should define fit-for-purpose performance criteria before selecting a model, including cellular composition, maturation, reproducibility, throughput, and relevance to the target question. Investment should favor standardized protocols, reference materials, longitudinal quality controls, and interoperable data structures. Partnerships among laboratories, clinicians, technology providers, and regulators can improve external validation and accelerate translation. Organizations should also establish governance for donor consent, genomic privacy, AI explainability, biosafety, and ethical boundaries, while training multidisciplinary teams capable of connecting model outputs with clinical and pharmacological evidence.

Methodology: Evidence-Based Synthesis of the Human Brain Models Landscape

This executive summary is structured as a qualitative synthesis of the human brain models domain, organized across technological change, artificial intelligence, geography, international groupings, countries, and strategic implications. The analysis distinguishes established capabilities and documented research directions from forward-looking interpretation. It avoids unsupported numerical claims and does not infer market size, shares, or forecasts. Regional and country narratives reflect differences in research infrastructure, scientific specialization, regulatory context, collaboration patterns, and translational potential.

Human Brain Models Will Advance Through Rigor and Responsible Integration

Human brain models are becoming more useful as researchers improve biological complexity while strengthening reproducibility and validation. The strongest progress will come from integrating engineered tissues, advanced imaging, computational analysis, and clinically anchored datasets rather than relying on any single model type. Organizations that combine scientific rigor with responsible governance, interoperable data practices, and cross-border collaboration will be better positioned to translate these systems into credible insights for neuroscience, disease research, and therapeutic development.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Human Brain Models Market, by Disease Model
7.1. Introduction
7.2. Alzheimer's
7.3. Epilepsy
7.4. Parkinson's
7.5. Stroke
8. Human Brain Models Market, by Technology
8.1. Introduction
8.2. Biofabrication
8.3. Microfluidics
8.3.1. Droplet Microfluidics
8.3.2. Organ-on-Chip
8.4. Neural Interface
8.4.1. In Vitro Electrophysiology
8.4.2. In Vivo Recording
8.5. Organoid Culture
8.5.1. Scaffold-Based
8.5.2. Scaffold-Free
9. Human Brain Models Market, by Application
9.1. Introduction
9.2. Drug Discovery
9.2.1. High Throughput Screening
9.2.2. Lead Optimization
9.3. Neuroscience Research
9.3.1. Alzheimer's Research
9.3.2. Parkinson's Research
9.3.3. Stroke Studies
9.4. Personalized Medicine
9.5. Toxicology Testing
10. Human Brain Models Market, by End User
10.1. Introduction
10.2. Academia
10.2.1. Research Institutes
10.2.2. Universities
10.3. Contract Research Organizations
10.4. Hospitals & Clinics
10.5. Pharma & Biotech
10.5.1. Large Pharma
10.5.2. Small & Mid-Size Biotech
11. Human Brain Models Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Human Brain Models Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Human Brain Models Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. 3D Systems, Inc.
15.2. Anatomy Warehouse, LLC
15.3. Brainlab AG
15.4. EISCO Scientific
15.5. ESP Models
15.6. GE HealthCare Technologies Inc.
15.7. Global Plastics, Inc.
15.8. GPI Anatomicals
15.9. Koninklijke Philips N.V.
15.10. Materialise NV
15.11. Medtronic plc
15.12. Organovo Holdings, Inc.
15.13. Scientific Accessories, Inc.
15.14. Siemens Healthineers AG
15.15. SmartLabs Education Ltd.
15.16. Stratasys Ltd.
15.17. Stryker Corporation
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Human Brain Models Market, Years Considered for the Study
FIGURE 2. Global Human Brain Models Market, Research Design
FIGURE 3. Global Human Brain Models Market, Research Framework
FIGURE 4. Global Human Brain Models Market, Data Triangulation
FIGURE 5. Global Human Brain Models Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Human Brain Models Market Size, by Disease Model, 2025 vs 2032 (%)
FIGURE 7. Global Human Brain Models Market Size, by Disease Model, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Human Brain Models Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Human Brain Models Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Human Brain Models Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Human Brain Models Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Human Brain Models Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Human Brain Models Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Human Brain Models Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Human Brain Models Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Human Brain Models Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Human Brain Models Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Human Brain Models Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Human Brain Models Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Human Brain Models Market Segmentation & Coverage
TABLE 2. Global Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 3. Global Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 4. Global Alzheimer's Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Alzheimer's Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Alzheimer's Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Epilepsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Epilepsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Epilepsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Parkinson's Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Parkinson's Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Parkinson's Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Stroke Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Stroke Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Stroke Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 17. Global Biofabrication Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Biofabrication Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Biofabrication Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Microfluidics Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Microfluidics Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Microfluidics Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Droplet Microfluidics Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Droplet Microfluidics Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Droplet Microfluidics Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Organ-on-Chip Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Organ-on-Chip Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Organ-on-Chip Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Neural Interface Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Neural Interface Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Neural Interface Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global In Vitro Electrophysiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global In Vitro Electrophysiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global In Vitro Electrophysiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global In Vivo Recording Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global In Vivo Recording Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global In Vivo Recording Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Organoid Culture Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Organoid Culture Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Organoid Culture Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Scaffold-Based Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Scaffold-Based Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Scaffold-Based Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Scaffold-Free Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Scaffold-Free Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Scaffold-Free Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 48. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global High Throughput Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global High Throughput Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global High Throughput Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Lead Optimization Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Lead Optimization Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Lead Optimization Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Neuroscience Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Neuroscience Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Neuroscience Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Alzheimer's Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Alzheimer's Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Alzheimer's Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Parkinson's Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Parkinson's Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Parkinson's Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Stroke Studies Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Stroke Studies Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Stroke Studies Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Personalized Medicine Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Personalized Medicine Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Personalized Medicine Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Toxicology Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Toxicology Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Toxicology Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. Global Academia Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Academia Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Academia Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Universities Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Universities Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Universities Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Pharma & Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Pharma & Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Pharma & Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Large Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Large Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Large Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Small & Mid-Size Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Small & Mid-Size Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Small & Mid-Size Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Human Brain Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Asia-Pacific Human Brain Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Asia-Pacific Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 103. Asia-Pacific Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 104. Asia-Pacific Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 105. Asia-Pacific Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 106. Asia-Pacific Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 107. Asia-Pacific Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 108. Asia-Pacific Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 109. Asia-Pacific Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 110. Asia-Pacific Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 111. Asia-Pacific Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 113. North America Human Brain Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. North America Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 115. North America Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 116. North America Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 117. North America Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 118. North America Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 119. North America Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 120. North America Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 121. North America Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 122. North America Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. North America Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 124. North America Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 125. Latin America Human Brain Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Latin America Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 127. Latin America Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 128. Latin America Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 129. Latin America Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 130. Latin America Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 131. Latin America Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 132. Latin America Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 133. Latin America Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 134. Latin America Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 135. Latin America Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 136. Latin America Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 137. Europe Human Brain Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 138. Europe Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 139. Europe Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 140. Europe Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 141. Europe Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 142. Europe Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 143. Europe Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. Europe Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 145. Europe Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 146. Europe Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 147. Europe Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 148. Europe Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 149. Middle East Human Brain Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 150. Middle East Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 151. Middle East Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 152. Middle East Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 153. Middle East Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 154. Middle East Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 155. Middle East Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. Middle East Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 157. Middle East Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 158. Middle East Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Middle East Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 160. Middle East Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 161. Africa Human Brain Models Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Africa Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 163. Africa Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 164. Africa Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 165. Africa Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 166. Africa Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 167. Africa Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 168. Africa Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 169. Africa Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 170. Africa Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 171. Africa Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 172. Africa Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 173. Global Human Brain Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. ASEAN Human Brain Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. ASEAN Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 176. ASEAN Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 177. ASEAN Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 178. ASEAN Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 179. ASEAN Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 180. ASEAN Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. ASEAN Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 182. ASEAN Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 183. ASEAN Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 184. ASEAN Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 185. ASEAN Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 186. GCC Human Brain Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 187. GCC Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 188. GCC Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 189. GCC Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 190. GCC Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 191. GCC Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 192. GCC Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 193. GCC Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 194. GCC Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 195. GCC Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 196. GCC Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 197. GCC Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 198. European Union Human Brain Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 199. European Union Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 200. European Union Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 201. European Union Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 202. European Union Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 203. European Union Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 204. European Union Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 205. European Union Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 206. European Union Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 207. European Union Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. European Union Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 209. European Union Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 210. BRICS Human Brain Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. BRICS Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 212. BRICS Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 213. BRICS Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 214. BRICS Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 215. BRICS Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 216. BRICS Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 217. BRICS Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 218. BRICS Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 219. BRICS Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. BRICS Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 221. BRICS Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 222. G7 Human Brain Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. G7 Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 224. G7 Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 225. G7 Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 226. G7 Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 227. G7 Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 228. G7 Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 229. G7 Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 230. G7 Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 231. G7 Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 232. G7 Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 233. G7 Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 234. NATO Human Brain Models Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. NATO Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 236. NATO Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 237. NATO Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 238. NATO Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 239. NATO Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 240. NATO Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. NATO Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 242. NATO Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 243. NATO Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. NATO Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 245. NATO Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 246. Global Human Brain Models Market Size, by Country, 2017-2032 (USD Million)
TABLE 247. United States Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 248. United States Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 249. United States Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 250. United States Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 251. United States Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 252. United States Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 253. United States Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 254. United States Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 255. United States Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 256. United States Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. United States Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 258. United States Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 259. Canada Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 260. Canada Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 261. Canada Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 262. Canada Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 263. Canada Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 264. Canada Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 265. Canada Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. Canada Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 267. Canada Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 268. Canada Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 269. Canada Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 270. Canada Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 271. Mexico Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 272. Mexico Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 273. Mexico Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 274. Mexico Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 275. Mexico Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 276. Mexico Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 277. Mexico Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. Mexico Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 279. Mexico Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 280. Mexico Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. Mexico Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 282. Mexico Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 283. Brazil Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 284. Brazil Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 285. Brazil Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 286. Brazil Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 287. Brazil Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 288. Brazil Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 289. Brazil Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 290. Brazil Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 291. Brazil Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 292. Brazil Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 293. Brazil Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 294. Brazil Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 295. United Kingdom Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 296. United Kingdom Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 297. United Kingdom Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 298. United Kingdom Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 299. United Kingdom Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 300. United Kingdom Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 301. United Kingdom Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. United Kingdom Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 303. United Kingdom Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 304. United Kingdom Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. United Kingdom Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 306. United Kingdom Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 307. Germany Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 308. Germany Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 309. Germany Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 310. Germany Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 311. Germany Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 312. Germany Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 313. Germany Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 314. Germany Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 315. Germany Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 316. Germany Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. Germany Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 318. Germany Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 319. France Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 320. France Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 321. France Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 322. France Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 323. France Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 324. France Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 325. France Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 326. France Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 327. France Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 328. France Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 329. France Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 330. France Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 331. Russia Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 332. Russia Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 333. Russia Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 334. Russia Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 335. Russia Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 336. Russia Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 337. Russia Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 338. Russia Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 339. Russia Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 340. Russia Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 341. Russia Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 342. Russia Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 343. Italy Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 344. Italy Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 345. Italy Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 346. Italy Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 347. Italy Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 348. Italy Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 349. Italy Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 350. Italy Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 351. Italy Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 352. Italy Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 353. Italy Human Brain Models Market Size, by Academia, 2017-2032 (USD Million)
TABLE 354. Italy Human Brain Models Market Size, by Pharma & Biotech, 2017-2032 (USD Million)
TABLE 355. Spain Human Brain Models Market Size, 2017-2032 (USD Million)
TABLE 356. Spain Human Brain Models Market Size, by Disease Model, 2017-2032 (USD Million)
TABLE 357. Spain Human Brain Models Market Size, by Technology, 2017-2032 (USD Million)
TABLE 358. Spain Human Brain Models Market Size, by Microfluidics, 2017-2032 (USD Million)
TABLE 359. Spain Human Brain Models Market Size, by Neural Interface, 2017-2032 (USD Million)
TABLE 360. Spain Human Brain Models Market Size, by Organoid Culture, 2017-2032 (USD Million)
TABLE 361. Spain Human Brain Models Market Size, by Application, 2017-2032 (USD Million)
TABLE 362. Spain Human Brain Models Market Size, by Drug Discovery, 2017-2032 (USD Million)
TABLE 363. Spain Human Brain Models Market Size, by Neuroscience Research, 2017-2032 (USD Million)
TABLE 364. Spain Human Brain Models Market Size, by End User, 2017-2032 (USD Million)
TABLE 365. Spain Huma

Companies Mentioned

  • 3D Systems, Inc.
  • Anatomy Warehouse, LLC
  • Brainlab AG
  • EISCO Scientific
  • ESP Models
  • GE HealthCare Technologies Inc.
  • Global Plastics, Inc.
  • GPI Anatomicals
  • Koninklijke Philips N.V.
  • Materialise NV
  • Medtronic plc
  • Organovo Holdings, Inc.
  • Scientific Accessories, Inc.
  • Siemens Healthineers AG
  • SmartLabs Education Ltd.
  • Stratasys Ltd.
  • Stryker Corporation

Related Topics

Related Reports

Human Brain Anatomy Models Market - Global Forecast 2026-2032 - Product Image

Human Brain Anatomy Models Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Human Digestive System Models Market - Global Forecast 2026-2032 - Product Image

Human Digestive System Models Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Virtual Human Anatomy Software Market Report 2026 - Product Image

Virtual Human Anatomy Software Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Bone Marrow Transplant - Global Strategic Business Report - Product Image

Bone Marrow Transplant - Global Strategic Business Report

  • Report
  • 371 Pages
  • Global
From
Virtual Human Anatomy Software Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Virtual Human Anatomy Software Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 224 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.